Clinical Trial Update: A Clinical Study to Evaluate the Efficacy and Safety of TQB3702 Tablets Combined With Immunochemotherapy for the Treatment of B-cell Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical study evaluating TQB3702 tablets with immunochemotherapy for B-cell lymphoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Lymphoma

Drugs mentioned

• TQB3702

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: B-cell Lymphoma | Phase 2 | Status: RECRUITING